A study of psychological pain in substance use disorder and its relationship to treatment outcome.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
15
04
2019
accepted:
23
10
2019
entrez:
8
11
2019
pubmed:
8
11
2019
medline:
17
3
2020
Statut:
epublish
Résumé
Substance Use Disorder (SUD) is a major public health concern affecting an estimated 22.5 million individuals in the United States. The primary aim of this study was to characterize psychological pain in a cohort of patients participating in outpatient treatment for SUD. A secondary aim was to determine the relationships between pre-treatment assessments of psychological pain, depression, anxiety and hopelessness with treatment retention time and completion rates. Data was analyzed from 289 patients enrolled in an outpatient community drug treatment clinic in Southern California, U.S. A previously determined threshold score on the Mee-Bunney Psychological Pain Assessment Scale (MBP) was utilized to group patients into high and low-moderate scoring subgroups. The higher pain group scored higher on measures of anxiety, hopelessness and depression compared to those in the low-moderate pain group. Additionally, patients scoring in the higher psychological pain group exhibited reduced retention times in treatment and more than two-fold increased odds of dropout relative to patients with lower pre-treatment levels of psychological pain. Among all assessments, the correlation between psychological pain and treatment retention time was strongest. To our knowledge, this is the first study to demonstrate that psychological pain is an important construct which correlates with relevant clinical outcomes in SUD. Furthermore, pre-treatment screening for psychological pain may help target higher-risk patients for clinical interventions aimed at improving treatment retention and completion rates.
Identifiants
pubmed: 31697679
doi: 10.1371/journal.pone.0216266
pii: PONE-D-19-10784
pmc: PMC6837512
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0216266Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Psychother Psychosom. 2014;83(1):62-3
pubmed: 24281693
J Nerv Ment Dis. 1993 Mar;181(3):145-7
pubmed: 8445372
J Consult Clin Psychol. 1974 Dec;42(6):861-5
pubmed: 4436473
Suicide Life Threat Behav. 2003 Fall;33(3):231-41
pubmed: 14582834
Addict Behav. 2016 Jul;58:129-35
pubmed: 26925821
Isr J Psychiatry Relat Sci. 2003;40(3):191-201
pubmed: 14619678
Suicide Life Threat Behav. 2003 Fall;33(3):242-8
pubmed: 14582835
Suicide Life Threat Behav. 2012 Apr;42(2):147-56
pubmed: 22324750
J Clin Psychol. 2012 Sep;68(9):1019-27
pubmed: 22644790
Mil Med. 2017 Jan;182(1):e1589-e1595
pubmed: 28051978
Clin Psychol Rev. 2013 Dec;33(8):1010-24
pubmed: 24029221
Plast Reconstr Surg. 2010 Dec;126(6):2234-42
pubmed: 20697313
Suicide Life Threat Behav. 2008 Feb;38(1):116-21
pubmed: 18355113
J Pers Assess. 1996 Dec;67(3):588-97
pubmed: 8991972
Psychiatriki. 2011 Oct-Dec;22(4):330-40
pubmed: 22271846
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
PLoS One. 2017 May 30;12(5):e0177974
pubmed: 28558020
Subst Abuse. 2018 Feb 28;12:1178221818760551
pubmed: 29531472
Eur J Pharmacol. 2015 Apr 15;753:73-87
pubmed: 25583178
Brain Imaging Behav. 2013 Sep;7(3):245-7
pubmed: 23640703
Suicide Life Threat Behav. 2010 Oct;40(5):476-91
pubmed: 21034210
Curr Psychiatry Rep. 2018 Apr 5;20(5):33
pubmed: 29623441
Soc Psychiatry Psychiatr Epidemiol. 2014 Mar;49(3):405-15
pubmed: 23995521
J Stud Alcohol Drugs. 2012 Mar;73(2):216-25
pubmed: 22333329
J Psychiatr Res. 2011 Nov;45(11):1504-10
pubmed: 21831397